ABOUT THE ETHA

The European Thrombosis and Haemostasis Alliance (ETHA) provides the thrombosis and hemostasis community with a unified voice and advocates for the prioritisation of these critical areas within EU patient safety and research agendas. Together, our members raise awareness of bleeding and clotting disorders and actively engage with the public and decision-makers to shape EU health strategies.

ETHA is committed to advancing transformative scientific research, promoting best clinical practices, and supporting the development of early career professionals. We champion the continuous education of physicians, scientists and allied health professionals—working to improve care for people across Europe.

ETHA was established by, and is funded and administered through, the International Society on Thrombosis and Haemostasis (ISTH). Its work is guided by a formal Memorandum of Understanding (MoU) between ETHA and ISTH.

Contact

OUR COMMITMENT

Raise awareness of thrombosis and hemostasis among the public and EU policymakers by highlighting critical unmet health needs.
Influence EU health and patient safety policies through strategic partnerships, positioning ETHA as a trusted expert resource for decision-makers.
Advocate for the integration of thrombosis and hemostasis priorities within EU research, patient safety, and health resilience programmes.
Promote the adoption of best practices and harmonised standards across Member States to enhance patient care and health outcomes.
Mobilise investment in thrombosis and hemostasis research, fostering public-private partnerships to accelerate innovation.
Support equitable access to new medical technologies, treatments and preventive measures that improve the lives of patients and society.

INTERESTED IN JOINING ETHA?

By becoming a member of ETHA, you join a network of leading experts and organisations dedicated to advancing thrombosis and hemostasis across Europe. Together, we combine knowledge, experience, and passion to drive meaningful change.

What We Offer Our Members:

Expertise: Collaborate with top specialists committed to improving research, education and patient care.
Collaboration: Engage in partnerships with key stakeholders to amplify your impact across Europe and beyond.
Innovation: Access cutting-edge research and educational resources to stay at the forefront of the field.
Advocacy: Play an active role in shaping policies that improve health outcomes for patients affected by thrombosis and hemostasis.

As a member, individuals and organisations can participate in ETHA’s educational programmes, research initiatives, and advocacy efforts—helping to influence public affairs at the European Parliament and other EU bodies. Members also benefit from exclusive access to a broad network of expertise and resources to support their work.

Join us in shaping the future of thrombosis and hemostasis care. Together, we can make a difference.

METTINE BOS, Ph.D.

Chair, ETHA

Mettine Bos, Ph.D. is an assistant professor at the Leiden University Medical Center in the Netherlands. She completed her doctorate in biochemistry at Utrecht University. Her research interests are Biochemistry, Hematology, Molecular Biology, Cell Biology, Genetics, and Life Sciences.

SABINE EICHINGER, M.D.

Chair-Elect, ETHA

Prof. Dr. Sabine Eichinger is a professor in the Department of Hematology at the Medical University of Vienna, where she serves as deputy head of the department and leads the outpatient hemostaseology unit. She is an internationally recognized expert in blood coagulation disorders and thromboembolic diseases, with extensive clinical and research experience. Prof Dr. Eichinger chaired the Scientific and Standardizing Committee of the International Society on Thrombosis and Haemostasis, and was a board member of the European Hematology Association. She authored numerous highly ranked scientific articles and received several prestigious academic awards.

LOUISE ST. GERMAIN

ISTH Staff Support, ETHA

Louise St. Germain has been with the International Society on Thrombosis and Haemostasis (ISTH) for over 13 years, where she has played a key role in developing and supporting global initiatives. She helped launch the ISTH World Thrombosis Day campaign in 2014 and has contributed significantly to the growth of the ISTH External Relations program. Louise brings extensive experience in marketing and communications to ETHA, supporting its mission through strategic collaboration and stakeholder engagement.

BUILDING ALLIANCES

thrombosis hemostasis european public affairs

Our advocacy efforts aim to prioritize VTE prevention and give the thrombosis and hemostasis community in the EU a unified voice. We provide input to EU health and patient safety strategies, recommend EU research program funding, and encourage the sharing and adoption of best practices.

Advocacy

thrombosis hemostasis public affairs ETHA alliance

We prioritize and proactively address public policy issues related to thrombosis and hemostasis and support MEPs and their staff - as well as the media - with resources, including research updates, and distribute basic information, papers, and informational resources to public affairs audiences.

Knowledge Exchange

Public health advocacy alliance in the European Union

In the EU, we provide public affairs training to our volunteers and a fine-tuned public affairs toolkit for outreach to public officials. We also convene relevant groups and contribute to high-level events to spread information about the field.

Training and Mobilization

thrombosis hemostasis public health advocacy in the EU

Community building is crucial in the EU to raise awareness about important health issues, such as thrombosis and hemostasis, and to promote the adoption of policies that improve patient outcomes. By engaging with policymakers and other relevant stakeholders, we can build a stronger and more supportive community.

Community Building

NEWS AND INSIGHTS

The European Thrombosis and Haemostasis Alliance (ETHA) blog features the latest news, policy updates, research highlights, funding opportunities and upcoming events relevant to our Alliance members and the broader thrombosis and hemostasis community across Europe.

READ THE NEWS